Hims Hers Health Inc - Asset Resilience Ratio
Hims Hers Health Inc (HIMS) has an Asset Resilience Ratio of 12.72% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check HIMS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Hims Hers Health Inc's Asset Resilience Ratio has changed over time. See HIMS equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Hims Hers Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HIMS market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $283.97 Million | 12.72% |
| Total Liquid Assets | $283.97 Million | 12.72% |
Asset Resilience Insights
- Moderate Liquidity: Hims Hers Health Inc has 12.72% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Hims Hers Health Inc Industry Peers by Asset Resilience Ratio
Compare Hims Hers Health Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Huadong Medicine Co Ltd
SHE:000963 |
Drug Manufacturers - Specialty & Generic | 0.05% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
|
Celltrion Pharm Inc
KQ:068760 |
Drug Manufacturers - Specialty & Generic | 12.49% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for Hims Hers Health Inc (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Hims Hers Health Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.26% | $79.67 Million | $707.54 Million | -16.92pp |
| 2023-12-31 | 28.18% | $124.32 Million | $441.19 Million | -8.09pp |
| 2022-12-31 | 36.26% | $132.85 Million | $366.34 Million | -5.46pp |
| 2021-12-31 | 41.73% | $175.49 Million | $420.58 Million | -19.66pp |
| 2020-12-31 | 61.39% | $72.86 Million | $118.70 Million | +9.05pp |
| 2019-12-31 | 52.34% | $37.72 Million | $72.07 Million | -- |
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provi… Read more